EvaluatePharma

Activities: Media

Trending Articles

  1. Olon releases its annual ESG report The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in...
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  4. CDMO GBI Biomanufacturing expands US drug product services with aseptic fill/finish capabilities Its Florida site will now be able to support biopharma clients from clinical trials to commercialisation with a dual manual/automated fill/finish approach
  5. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Media

Worldwide prescription drug sales accelerate to $1.2 trillion by 2024

Orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market
Media

What’s in store for 2018 in the pharma and biotech industry?

The upward momentum seen in the pharma and biotech sectors during 2017 looks set to continue into 2018, with more novel medicines preparing to hit the market and investor support for the industry remaining strong
Media

Japanese pharmaceutical market set to grow

According to Evaluate, a life science commercial intelligence firm, the Japanese pharmaceutical market is set to grow at a compounded average growth rate (CAGR) of 3.3% between 2017 and 2022, significantly lower than the worldwide outlook (6.5% CAGR)
Media

Pricing pressure causes worldwide drug sales forecasts to fall for first time in 10 years

Increased scrutiny around the pricing of medicines is starting to have an impact on drug sales growth, according to Evaluate’s latest World Preview report
Media

Worldwide prescription drug sales to top trillion dollar mark in 2022

More than 30% of the 2022 increase in sales to come from orphan drugs
Pharmaceutical

Orphan drug market growing, despite high costs

Median cost per patient for orphan drugs is 5.5 times higher than non-orphan drugs, according to “EvaluatePharma Orphan Drug 2017 Report”
Media

Worldwide prescription drug sales forecast to grow 6.3%

But political pressure over pricing could put a damper on uninerrupted growth, report warns
Subscribe now